News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel

News, Analysis, Trends, Management Innovations for
Clinical Laboratories and Pathology Groups

Hosted by Robert Michel
Sign In

Everything You Need to Know about Washington, DC: Issues of Concern to Labs, Including PAMA, VALID Act, FDA, OIG, CMS, Congress, and More

A Panel discussion featuring:

Jeff Allen, PhD, Susan Van Meter, Emily Volk, MD, Laura Tafe, MD, and John Kolozsvary

Everything You Need to Know about Washington, DC: Issues of Concern to Labs, Including PAMA, VALID Act, FDA, OIG, CMS, Congress, and More

by Jeff Allen, PhD, Susan Van Meter, Emily Volk, MD, Laura Tafe, MD, John Kolozsvary

Panel: State of the IVD Industry: What’s Working Best
in Today’s Post-Pandemic Market for Lab Vendors and
Their Customers’

A Panel discussion featuring:

Bruce Carlson, James Kathrein, Robert McGonnagle, and Larry Worden

Panel: State of the IVD Industry: What’s Working Best in Today’s Post-Pandemic Market for Lab Vendors and Their Customers’

by Bruce Carlson, James Kathrein, Robert McGonnagle, Larry Worden

Progressive Steps to Solve Pain Points in Lab Revenue Cycle Management: Deploying AI-Powered Solutions, Improving Cash Flow Projections, and Collecting Accurate, Complete Data with the Lab Request

Presented by:

Ted Kanuf and Michael Tarwater

Progressive Steps to Solve Pain Points in Lab Revenue Cycle Management: Deploying AI-Powered Solutions, Improving Cash Flow Projections, and Collecting Accurate, Complete Data with the Lab Request

by Ted Knauf and Michael Tarwater

Five Issues that Keep New CLIA Laboratory Directors Up at Night: Compliance Requirements, Changes in Enforcement, Overlooked Sources of Risk

Presented by:

Lindsay Strotman, PhD and Nora Hess, MBA

Five Issues that Keep New CLIA Laboratory Directors Up at Night: Compliance Requirements, Changes in Enforcement, Overlooked Sources of Risk

by Lindsay Strotman, PhD & Nora Hess, MBA, MT (ASCP), PMP

;